论文部分内容阅读
1967年以来国外已利用短小棒状杆菌(CP)作为一些肿瘤的免疫治疗剂,同时也开展了许多有关机理的实验研究。但是对它的抗瘤机理仍不十分清楚。Prevot实验室认为是刺激网状内皮系统。一般认为菌苗的抗癌作用是通过激活巨噬细胞而实现的。由卫生部药品生物制品检定所、上海
Since 1967, Corynebacterium parvum (CP) has been used as an immunotherapeutic agent for some tumors, and many experimental studies on the mechanism have also been carried out. However, its anti-tumor mechanism is still not very clear. Prevot Labs believes it stimulates the reticuloendothelial system. It is generally believed that the anti-cancer effect of bacterins is achieved by activating macrophages. From the Ministry of Health Pharmaceutical and Biological Products Verification Institute, Shanghai